- Angiotensin-I-converting enzyme and its relativesJames F Riordan
Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, One Kendall Square, Cambridge, MA 02139, USA
Genome Biol 4:225. 2003..Structure-based drug design targeting the individual active sites of somatic ACE may lead to a new generation of ACE inhibitors, with fewer side-effects than currently available inhibitors...
- Ace revisited: a new target for structure-based drug designK Ravi Acharya
Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK
Nat Rev Drug Discov 2:891-902. 2003